StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.78+0.01 (+1.18%)

Close on Nov 17, 2026Market cap $9.26MP/E –Yield –

CytoMed Therapeutics total assets

Total assets on the balance sheet at the end of each period.

CytoMed Therapeutics's total assets was 7.98M SGD at Dec 31, 2025. For fiscal 2025 it was 7.98M SGD, down 20.7% from the year before. The highest annual figure on record is 12.37M SGD in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 20257.98M SGD-20.7%
FY2024Dec 31, 202410.07M SGD-18.6%
FY2023Dec 31, 202312.37M SGD+136.6%
FY2022Dec 31, 20225.23M SGD-14.1%
FY2021Dec 31, 20216.08M SGD–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 20257.98M SGD+31.3%
Q4 FY2024Dec 31, 202410.07M SGD–
Q4 FY2023Dec 31, 202312.37M SGD–
Q4 FY2022Dec 31, 20225.23M SGD–
Q4 FY2021Dec 31, 20216.08M SGD–

More CytoMed Therapeutics figures

See a number that looks wrong?